Blood cancer Clinical Trials in Commack, NY
As of June 2026, 41 paid clinical trials are recruiting for Blood cancer in Commack, New York. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
41 clinical trials for Blood cancer
·Clear filters·↓ Download CSVA Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Revumenib and Mezigdomide in People With Leukemia
A Dietary Study for People With Multiple Myeloma
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
About research studies in Commack
Commack has approximately 322 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Commack
Researchers run research studies in Commack, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Commack | Acute Myeloid Leukemia, Breast Cancer, Stage IV Lung Cancer AJCC v8 | 68 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Multiple Myeloma, Breast Cancer, Glioma | 39 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Anastomotic Leak | 16 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Adnexal Carcinoma | 12 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Acute Myeloid Leukemia, Bladder Cancer, Brain Tumor | 12 |
| Memorial Sloan Kettering Commack (Limited Protocol Activities) | Breast Cancer, Metastatic Breast Cancer, Brain Tumor | 11 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Gastric Adenocarcinoma, Gastric Cancer, Caregiver Burden | 10 |
| Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) | Cancer, Breast Cancer Survivor, Cancer Pain | 8 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer | 8 |
| MSK Commack | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 7 |
| Memorial Sloan Kettering Suffolk-Commack (Consent only) | High-risk Neuroblastoma, Metastatic Neuroblastoma, Neuroblastoma | 7 |
| Memorial Sloan Kettering Suffolk - Commack | Autoimmune Lymphoproliferative, Brain Metastases, Brain Metastases, Adult | 6 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) | Metastatic Breast Cancer, Bone Sarcoma, Breast Cancer | 6 |
| Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) | Ovarian Cancer, Alveolar Soft Part Sarcoma, Extramammary Paget's Disease | 5 |
| Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities) | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Metastatic Renal Cell Carcinoma | 5 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 5 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) | HNSCC, Head Cancer, Head Cancer Neck | 5 |
| Memorial Sloan Kettering Commack (All Protocol Activities) | Endometrial Cancer, Endometrial Cancer Stage I, Endometrioid Adenocarcinoma | 5 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Endometrial Cancer, Non-Muscle Invasive Bladder Cancer, Non-Small Cell Lung Cancer | 5 |
| Memorial Sloan Kettering Cancer Center @ Commack | Colorectal Cancer, Colorectal Carcinoma, Hodgkin Lymphoma | 4 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) | Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV | 4 |
| True North Neurology | Acute Treatment of Migraine, Migraine, Pediatric Migraine | 4 |
| Memorial Sloan Kettering Commack (Consent Only) | Adolescents and Young Adults With Cancer, Radiation Therapy, Breast Cancer | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) | Breast Cancer, Cushing Disease, Cushing Syndrome | 3 |
| Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hairy Cell Leukemia | 3 |
Active & Upcoming Studies in Commack (2026)
Recruiting trials in Commack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (253 active studies)
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Study of MSK-TCR5 in People With Solid Tumor Cancers · Phase 1 · Memorial Sloan Kettering Cancer Center
Neurology & pain (9 active studies)
- A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain · Phase 1 · Memorial Sloan Kettering Cancer Center
- Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: · Supernus Pharmaceuticals, Inc.
Pediatric (3 active studies)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
Vaccines (1 active study)
HIV / STI (1 active study)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma · Phase 2 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Commack
- Breast Cancer (28 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (13 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (11 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Prostate Cancer (11 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Endometrial Cancer (10 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Metastatic Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Commack
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Commack. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Commack
Hipa.ai aggregates every recruiting study in Commack from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Commack?
There are approximately 322 recruiting clinical trials in Commack, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Commack pay participants?
Most recruiting trials in Commack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Commack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Commack?
The most common conditions under active study in Commack include Breast Cancer (28), Multiple Myeloma (13), Acute Myeloid Leukemia (11), Prostate Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Commack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Commack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Commack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Commack?
Recruiting research sites in Commack include Memorial Sloan Kettering Commack, Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Commack right now?
The largest active categories in Commack are Cancer & tumors (253), Neurology & pain (9), Pediatric (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.